So much for ceasefires
CLOSING BELL
Happy Monday
Monday started the week with a slight decline as the market was holding its breath after hitting all-time highs on Friday following Iran ceasefire news. The S&P 500 ended the day barely clinging to 7,100. As it turns out the grand reopening of the strait is on hold. So much for a ribbon cutting ceremony: the Hormuz standoff is back on with Iran and the U.S. both refusing to budge their blockades. ✂️
President Trump said he won’t extend the ceasefire that is set to time out Wednesday. The admin also said a third cabinet member is stepping down: Labor Secretary Lori Chavez-Deremer. She is under investigation internally for allegations of workplace misconduct.
After the bell, news dropped in the tech world. Apple found a new CEO to replace Tim Cook this year, and Anthropic and Amazon came through with a compute AWS and investment deal.
The top story today outside the war is the persistent post-earnings selloff in $NFLX ( ▼ 2.55% ) . Netflix is dominating Stocktwits today, with over 517,000 watchers watching the stock slide 7% since its report last week. It’s setting the table for a massive week of tech earnings:
Heavyweights $TSLA, $INTC, and $IBM have to prove that their recent runs were built on real orders. Retail is watching with bated breath, and Wednesday’s ceasefire end mixed with Tesla reports may really shake things up this week.
AFTER THE BELL
Apple Picks Its Operator
Apple handed the top job to John Ternus on Monday, ending Tim Cook’s long run in the corner office and setting up the company’s first real leadership reset since the Steve Jobs era. The news landed after the close, as investors weighed whether a hardware leader is the right pick for a company under pressure to show more urgency on AI.
The RIP: $AAPL was down 0.53% late Monday. Ternus becomes CEO on Sept. 1 and joins the board. Cook becomes executive chairman. Apple closed with a $4T market cap, and revenue reached more than $400B in the latest fiscal year.
What matters now is whether Ternus can prove he is more than a steady hardware hand. Apple’s next leg depends on fixing Siri, shipping a credible AI strategy, and managing tariffs and supply chain risk without losing margin discipline. If the company still looks late on AI by next year, the succession story stops looking smooth and starts looking defensive. 🍎
MORE AFTER THE BELL
Amazon Buys More Compute Time ☁️
Amazon tightened its grip on one of the most important AI customers in the market on Monday, using fresh capital to lock Anthropic deeper into its cloud and chip stack. The deal reads less like a venture bet and more like a long-term infrastructure reservation as hyperscalers race to secure model builders before capacity gets spoken for.
The RIP: $AMZN ( ▼ 0.91% ) will invest $5B in Anthropic now, with up to $20B more tied to commercial milestones, on top of the $8B already invested. Anthropic committed to spend more than $100B on AWS over 10 years and secured up to 5 gigawatts of capacity.
What matters is that Amazon is turning AI capex into contracted demand rather than just speculative buildout. Holders should watch whether these AWS commitments translate into durable cloud growth and Trainium adoption, because the bear case is still that Amazon spends aggressively while Nvidia based ecosystems keep winning the most valuable workloads. This also raises the pressure on Microsoft and Google to keep paying for model access and capacity locks. ☁️
HEALTHCARE NEWS
The Psychedelic Regulatory Thaw
Clinical-stage biotech firms $CMPS and $PBM surged on Monday as shifting U.S. regulatory frameworks and new grant initiatives signaled a clear path toward the commercialization of psychedelic-assisted therapies. President Trump signed an EO directing regulators to speed up reviews of psychedelic drugs, and boost research attempts. The order was issued Saturday, and sent names like Definium Therapeutics and Compass Pathways higher.
The RIP: $CMPS ( ▲ 42.04% ) jumped +42% after launching a U.S. grant program to train healthcare providers for the COMP360 psilocybin launch; $PBM ( ▲ 48.68% ) soared +49% following its announcement of a clinical trial collaboration for mental health treatments. The order tells the FDA to issue Commissioners National Priority Vouchers, according to Reuters. 🍄
SECTOR NEWS
Infrastructure Powers the AI Pivot
A broad basket of hardware and enterprise software names including $ARM, $MRVL, $TTD, $TEAM, $HPE, and $POET rallied Monday as corporate spending reports confirmed a massive second-wave shift toward specialized AI infrastructure. The rally suggests that the “AI trade” is evolving from chip designers to the networking and platform layers that facilitate deployment. All eyes are watching for some major earnings reports this week for more.
The RIP: $ARM ( ▲ 5.02% ) saw a +5% lift after Guggenheim raised its price target to $240, citing custom silicon demand. $MRVL ( ▲ 5.83% ) gained +6% on reports of a joint AI chip development deal with Alphabet, according to Bloomberg.⚡
TRENDING STOCKS
Pops & Drops
-
$AVEX ( ▲ 24.06% ) AEVEX Corp: rose +24% after doubling IPO price in two days
-
$CAR ( ▲ 23.27% ) Avis Budget Group: rose +23% after massive short squeeze
-
$TTD ( ▲ 7.03% ) Trade Desk: rose +7% after reporting record high connected TV ad spend
-
$TEAM ( ▲ 6.78% ) Atlassian: rose +7% after Morgan Stanley upgraded to overweight
-
$TMC ( ▲ 6.39% ) TMC the metals company: rose +6% after receiving sub-sea mineral mining updates
-
$MAAS ( ▲ 5.08% ) Highest Performances: rose +5% after announcing new UAE data center contract
-
$GRRR ( ▲ 9.9% ) Gorilla Technology: rose +10% after increasing strategic investment in Astrikos AI
-
$BULL ( ▲ 4.32% ) Webull Corp: rose +4% after SEC approved new retail trading rules
-
$BSX ( ▼ 5.04% ) Boston Scientific: fell -5% after risk-off positioning ahead of Wednesday results
-
$NRG ( ▼ 6.29% ) NRG Energy: fell -6% after analysts lowered Q2 power demand forecasts
THE CASHTAG AWARDS
The BIGGEST night in Finance. May 4th. NYSE.
The Cashtag Awards are built by the Stocktwits community and it wouldn’t be the same without you in the room!
We’re offering a limited number of fully comped tickets for members who want to show up, represent, and help make this night as special as it should be.
Want to celebrate with us on May 4th?
TRENDING STORIES
ST Retail Gets Launch Reality Check 🚀
AST SpaceMobile sold off after Blue Origin’s first commercial New Glenn mission failed to place BlueBird 7 into the right orbit, turning what was supposed to be a showcase launch into a loss of a key satellite. The setback hit the stock hard, a retail favorite on Stocktwits that faced high volatility last week in the lead up to its April 16 launch. The stock trades heavily on execution milestones, not just its long-range vision of space-based cellular coverage. The vision is cool and all, space phones, but the company needs to get their tech into space in the first place.
The RIP: $ASTS ( ▼ 5.3% ) fell 5.3% after Blue Origin said BlueBird 7 was placed into an off-nominal orbit. AST said the satellite’s altitude was too low to sustain operations and that it will be deorbited. The company said the loss is expected to be covered by insurance and still expects launches every 1 to 2 months this year.
What matters now is whether AST can keep its deployment cadence intact, because this story only works if satellites get into orbit and stay there. Insurance helps on the financial hit, the firm said it should cover the cost of the satellite, but it does not recover lost time, and lost time is the real risk for a company racing to build network coverage before investor patience runs thin. Competitors and launch partners both stay under the microscope from here.
One wallstreetbets user said you could not make up a more ironic scenario, that the Blue Origin rocket launch seemed to botch its first major partner moment with AST, setting back the space cell phone project for months Competitors RocketLab and SpaceX are going to gain speed in the competitive space, the user argued. 🚀
WHAT’S ON DECK
Tomorrow’s Top Things 📋
Pre-Market Earnings: $GE GE Aerospace, $UNH UnitedHealth Group, $RTX RTX Corporation, $MMM 3m, $HAL Halliburton, +8 more. ☀️
After-Market Earnings: $UAL United Airlines Holdings, $VKTX Viking Therapeutics Inc, $ISRG Intuitive Surgical, $GFAI Guardforce AI Co Ltd, $NLY Annaly Capital Management Inc, +10 more. 🌙
P.S. You can listen to all of these earnings calls on Stocktwits.
Links That Don’t Suck 🌐
😨 Businesses race to apply for tariff refunds
🏠️ Labor Secretary Lori Chavez-DeRemer leaves Trump cabinet, Keith Sonderling takes over
🍻 FBI director Kash Patel files $250M defamation lawsuit against The Atlantic
📺️ Investors are misreading news about the Iran war, analysts say as markets whipsaw
Get In Touch 📬
Want to see some change? Email Kevin Travers feedback, follow him on Stocktwits. Refer a friend for this quarter’s edition of The RIP Forecast!
Refer a Friend 🍟 : Share with a simple click below, and receive a free copy of our first quarterly edition of the Daily Rip Equity Forecast!
Terms & Conditions 📝
Securities Disclaimer: STOCKTWITS IS NOT A TAX ADVISOR, BROKER, FINANCIAL ADVISOR OR INVESTMENT ADVISOR. THE SERVICE IS NOT INTENDED TO PROVIDE TAX, LEGAL, FINANCIAL OR INVESTMENT ADVICE, AND NOTHING ON THE SERVICE SHOULD BE CONSTRUED AS AN OFFER TO SELL, A SOLICITATION OF AN OFFER TO BUY, OR A RECOMMENDATION FOR ANY SECURITY. Trading in such securities can result in immediate and substantial losses of the capital invested. You should only invest risk capital and not capital required for other purposes. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should also consult an attorney or tax professional regarding your specific legal or tax situation. The content is to be used for informational and entertainment purposes only and the service does not provide investment advice for any individual. Stocktwits, its affiliates and partners specifically disclaim any and all liability or loss arising out of any action taken in reliance on content, including but not limited to market value or other loss on the sale or purchase of any company, property, product, service, security, instrument, or any other matter. You understand that an investment in any security is subject to a number of risks and that discussions of any security published on the Service will not contain a list or description of relevant risk factors. In addition, please note that some of the stocks about which content is published on the service have a low market capitalization and/or insufficient public float. Such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information. Read the full terms & conditions here. 🔍
Author Disclosure: The author of this newsletter does not hold positions in any of the securities or assets mentioned. 📋
